Fines of nearly €150 million imposed on pharmaceutical company Lundbeck and a number of generic rivals by the European Commission have been upheld by the EU General Court. The Court's decisions are the first to find that pay-for-delay agreements breach EU antitrust rules
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Penelope Aspinall, of wellbeing charity Jonathan’s Voice, explains why a newly published mental health hub for the IP community could prove to be a vital resource
Lucy Wheatley, partner at McGuireWoods, discusses the challenges of explaining trademarks to a jury and reveals a logistical hurdle she had to navigate